Changeflow GovPing Healthcare FDA Class II Device Recall: GEM Premier 5000 PAK
Urgent Enforcement Amended Final

FDA Class II Device Recall: GEM Premier 5000 PAK

Favicon for changeflow.com FDA: Device Recalls Class II
Filed March 18th, 2026
Detected March 29th, 2026
Email

Summary

The FDA has issued a Class II device recall for Instrumentation Laboratory's GEM Premier 5000 PAK due to an increased incidence of Process Control Solution Not Detected (PCSND) errors. This recall affects worldwide distribution, including the US.

What changed

The FDA has classified a recall of Instrumentation Laboratory's GEM Premier 5000 PAK (Part No. 00055360008) as Class II. The recall is due to confirmed customer complaints indicating an increased incidence of "Process Control Solution Not Detected" (PCSND) errors during warm-up, leading to GEM PAK ejection. This issue requires the insertion of a new cartridge.

Healthcare providers and facilities using the GEM Premier 5000 system should be aware of this recall and potential operational disruptions. While the document does not specify a compliance deadline for action, affected parties should consult Instrumentation Laboratory for guidance on addressing the PCSND errors and potential remediation steps. The recall has worldwide distribution, including the United States.

What to do next

  1. Review GEM Premier 5000 PAK usage for PCSND errors.
  2. Consult Instrumentation Laboratory for remediation guidance.
  3. Ensure affected devices are properly managed according to manufacturer instructions.

Source document (simplified)

Instrumentation Laboratory

Device Recalls (Class II)

← All Device Recalls (Class II) Class II Z-1525-2026 · 20260318 · Ongoing

Product

GEM Premier 5000 PAK; Part No. 00055360008.

Reason for Recall

Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...

Distribution

Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...

Source: openFDA Enforcement API

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Filed
March 18th, 2026
Instrument
Enforcement
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Z-1525-2026

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Recalls Product Safety
Geographic scope
United States US

Taxonomy

Primary area
Product Safety
Operational domain
Compliance
Topics
Medical Devices Healthcare

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when FDA: Device Recalls Class II publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.